» Articles » PMID: 15698857

Plasma Melatonin Concentrations in Hypertensive Patients with the Dipping and Non-dipping Blood Pressure Profile

Overview
Journal Life Sci
Publisher Elsevier
Date 2005 Feb 9
PMID 15698857
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Some patients with hypertension exhibit disturbed circadian organization in the cardiovascular system. Hormone melatonin can synchronize circadian rhythms and its repeated administration can improve synchronization of rhythmicity in blood pressure (BP). In our study we measured endogenous melatonin production in patients with essential hypertension exhibiting a dipping and non-dipping BP profile. Blood pressure was monitored for at least 24-hr with an automatic ambulatory BP monitor and patients with no decline in BP were classified as non-dippers. Plasma melatonin was measured in the middle of the daytime and night-time by radioimmunoassay. As expected night-time systolic (P <0.05), diastolic (P <0.001) and mean arterial (P <0.001) BP was higher in non-dippers than in dippers. No significant difference was found between both groups in BP during the day. Mean melatonin concentrations were higher during the night than during the day in both dippers and non-dippers. When patients were divided into dippers and non-dippers on the basis of mean arterial or diastolic BP a lower ratio of night/day concentration was determined in non-dippers than in dippers. Our study showed a blunted night/day difference in plasma melatonin concentrations in hypertensive patients with the non-dipping profile in diastolic BP indicating disturbances in the circadian system of these patients.

Citing Articles

Blunted circadian variation of blood pressure in individuals with neurofibromatosis type 1.

Cieza Rivera A, Fernandez-Villa T, Martin V, Atallah I Orphanet J Rare Dis. 2023; 18(1):164.

PMID: 37353803 PMC: 10290318. DOI: 10.1186/s13023-023-02766-7.


Impaired Melatonin Secretion, Oxidative Stress and Metabolic Syndrome in Night Shift Work.

Hohor S, Mandanach C, Maftei A, Zugravu C, Otelea M Antioxidants (Basel). 2023; 12(4).

PMID: 37107334 PMC: 10135726. DOI: 10.3390/antiox12040959.


Melatonin and Health: Insights of Melatonin Action, Biological Functions, and Associated Disorders.

Ahmad S, Ali A, Bilal M, Rashid S, Wani A, Bhat R Cell Mol Neurobiol. 2023; 43(6):2437-2458.

PMID: 36752886 PMC: 9907215. DOI: 10.1007/s10571-023-01324-w.


Hypotensive effects of melatonin in rats: Focus on the model, measurement, application, and main mechanisms.

Cvikova D, Sutovska H, Babarikova K, Molcan L Hypertens Res. 2022; 45(12):1929-1944.

PMID: 36123396 DOI: 10.1038/s41440-022-01031-x.


Benefits and adverse events of melatonin use in the elderly (Review).

Anghel L, Baroiu L, Risca Popazu C, Patras D, Fotea S, Nechifor A Exp Ther Med. 2022; 23(3):219.

PMID: 35126722 PMC: 8796282. DOI: 10.3892/etm.2022.11142.